APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Consumer Healthcare Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Consumer Healthcare Drug Market Analysis and Forecast 2026-2032

21 December 2025205 pages

Choose your research edition.

Industry ResearchConsumer Healthcare Drug Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Consumer Healthcare Drug Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Consumer Healthcare Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Consumer Healthcare Drug Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Consumer Healthcare Drug Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Consumer Healthcare Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Consumer Healthcare Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Consumer Healthcare Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Consumer Healthcare Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Consumer Healthcare Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Consumer Healthcare Drug include Takeda, Teva, Shanghai Pharmaceuticals, Sanofi, Johnson & Johnson, Merck & Co., Pfizer, Hualan Bio and North China Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Consumer Healthcare Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Consumer Healthcare Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Consumer Healthcare Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Consumer Healthcare Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Consumer Healthcare Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Consumer Healthcare Drug revenue, projected growth trends, production technology, application and end-user industry.

Consumer Healthcare Drug Segment by Company

Takeda

Teva

Shanghai Pharmaceuticals

Sanofi

Johnson & Johnson

Merck & Co.

Pfizer

Hualan Bio

North China Pharmaceutical

Hengrui Medicine

GlaxoSmithKline

Bayer

AbbVie

Sinopharm Group

Livzon Group

Fosun Pharma

East China Medicine

CR Pharmaceutical

Consumer Healthcare Drug Segment by Type

Patch

Oral Liquid

Solid Preparations

Other

Consumer Healthcare Drug Segment by Application

Hospital

Retail Pharmacy

Other

Consumer Healthcare Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Consumer Healthcare Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Consumer Healthcare Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Consumer Healthcare Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Consumer Healthcare Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Consumer Healthcare Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Consumer Healthcare Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Consumer Healthcare Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Patch Major Player Table 3. Oral Liquid Major Player Table 4. Solid Preparations Major Player Table 5. Other Major Player Table 6. Global Consumer Healthcare Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Retail Pharmacy Major Player Table 9. Other Major Player Table 10. Consumer Healthcare Drug Industry Trends Table 11. Consumer Healthcare Drug Industry Drivers Table 12. Consumer Healthcare Drug Industry Opportunities and Challenges Table 13. Consumer Healthcare Drug Industry Restraints Table 14. Global Consumer Healthcare Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Consumer Healthcare Drug Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Consumer Healthcare Drug Market Share by Region (2021-2026) Table 17. Global Consumer Healthcare Drug Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Consumer Healthcare Drug Market Share by Region (2027-2032) Table 19. Global Consumer Healthcare Drug Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Consumer Healthcare Drug Revenue Market Share by Players (2021-2026) Table 21. Global Consumer Healthcare Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Consumer Healthcare Drug Key Players Headquarters & Area Served Table 23. Global Consumer Healthcare Drug Players, Product Type & Application Table 24. Global Consumer Healthcare Drug Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Consumer Healthcare Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Consumer Healthcare Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Consumer Healthcare Drug Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Consumer Healthcare Drug Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Consumer Healthcare Drug Revenue Market Share by Type (2021-2026) Table 31. Global Consumer Healthcare Drug Revenue Market Share by Type (2027-2032) Table 32. Global Consumer Healthcare Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Consumer Healthcare Drug Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Consumer Healthcare Drug Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Consumer Healthcare Drug Revenue Market Share by Application (2021-2026) Table 36. Global Consumer Healthcare Drug Revenue Market Share by Application (2027-2032) Table 37. Takeda Company Information Table 38. Takeda Business Overview Table 39. Takeda Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Takeda Consumer Healthcare Drug Product Portfolio Table 41. Takeda Recent Development Table 42. Teva Company Information Table 43. Teva Business Overview Table 44. Teva Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Teva Consumer Healthcare Drug Product Portfolio Table 46. Teva Recent Development Table 47. Shanghai Pharmaceuticals Company Information Table 48. Shanghai Pharmaceuticals Business Overview Table 49. Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Shanghai Pharmaceuticals Consumer Healthcare Drug Product Portfolio Table 51. Shanghai Pharmaceuticals Recent Development Table 52. Sanofi Company Information Table 53. Sanofi Business Overview Table 54. Sanofi Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Sanofi Consumer Healthcare Drug Product Portfolio Table 56. Sanofi Recent Development Table 57. Johnson & Johnson Company Information Table 58. Johnson & Johnson Business Overview Table 59. Johnson & Johnson Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Johnson & Johnson Consumer Healthcare Drug Product Portfolio Table 61. Johnson & Johnson Recent Development Table 62. Merck & Co. Company Information Table 63. Merck & Co. Business Overview Table 64. Merck & Co. Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Merck & Co. Consumer Healthcare Drug Product Portfolio Table 66. Merck & Co. Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Pfizer Consumer Healthcare Drug Product Portfolio Table 71. Pfizer Recent Development Table 72. Hualan Bio Company Information Table 73. Hualan Bio Business Overview Table 74. Hualan Bio Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Hualan Bio Consumer Healthcare Drug Product Portfolio Table 76. Hualan Bio Recent Development Table 77. North China Pharmaceutical Company Information Table 78. North China Pharmaceutical Business Overview Table 79. North China Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. North China Pharmaceutical Consumer Healthcare Drug Product Portfolio Table 81. North China Pharmaceutical Recent Development Table 82. Hengrui Medicine Company Information Table 83. Hengrui Medicine Business Overview Table 84. Hengrui Medicine Consumer Healthcare Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Hengrui Medicine Consumer Healthcare Drug Product Portfolio Table 86. Hengrui Medicine Recent Development Table 87. GlaxoSmithKline Company Information Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Consumer Healthcare Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. GlaxoSmithKline Consumer Healthcare Drug Product Portfolio Table 91. GlaxoSmithKline Recent Development Table 92. Bayer Company Information Table 93. Bayer Business Overview Table 94. Bayer Consumer Healthcare Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Bayer Consumer Healthcare Drug Product Portfolio Table 96. Bayer Recent Development Table 97. AbbVie Company Information Table 98. AbbVie Business Overview Table 99. AbbVie Consumer Healthcare Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. AbbVie Consumer Healthcare Drug Product Portfolio Table 101. AbbVie Recent Development Table 102. Sinopharm Group Company Information Table 103. Sinopharm Group Business Overview Table 104. Sinopharm Group Consumer Healthcare Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Sinopharm Group Consumer Healthcare Drug Product Portfolio Table 106. Sinopharm Group Recent Development Table 107. Livzon Group Company Information Table 108. Livzon Group Business Overview Table 109. Livzon Group Consumer Healthcare Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Livzon Group Consumer Healthcare Drug Product Portfolio Table 111. Livzon Group Recent Development Table 112. Fosun Pharma Company Information Table 113. Fosun Pharma Business Overview Table 114. Fosun Pharma Consumer Healthcare Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Fosun Pharma Consumer Healthcare Drug Product Portfolio Table 116. Fosun Pharma Recent Development Table 117. East China Medicine Company Information Table 118. East China Medicine Business Overview Table 119. East China Medicine Consumer Healthcare Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. East China Medicine Consumer Healthcare Drug Product Portfolio Table 121. East China Medicine Recent Development Table 122. CR Pharmaceutical Company Information Table 123. CR Pharmaceutical Business Overview Table 124. CR Pharmaceutical Consumer Healthcare Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. CR Pharmaceutical Consumer Healthcare Drug Product Portfolio Table 126. CR Pharmaceutical Recent Development Table 127. North America Consumer Healthcare Drug Revenue by Type (2021-2026) & (US$ Million) Table 128. North America Consumer Healthcare Drug Revenue by Type (2027-2032) & (US$ Million) Table 129. North America Consumer Healthcare Drug Revenue by Application (2021-2026) & (US$ Million) Table 130. North America Consumer Healthcare Drug Revenue by Application (2027-2032) & (US$ Million) Table 131. North America Consumer Healthcare Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. North America Consumer Healthcare Drug Revenue by Country (2021-2026) & (US$ Million) Table 133. North America Consumer Healthcare Drug Revenue by Country (US$ Million) & (2027-2032) Table 134. Europe Consumer Healthcare Drug Revenue by Type (2021-2026) & (US$ Million) Table 135. Europe Consumer Healthcare Drug Revenue by Type (2027-2032) & (US$ Million) Table 136. Europe Consumer Healthcare Drug Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Consumer Healthcare Drug Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Consumer Healthcare Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Consumer Healthcare Drug Revenue by Country (2021-2026) & (US$ Million) Table 140. Europe Consumer Healthcare Drug Revenue by Country (US$ Million) & (2027-2032) Table 141. China Consumer Healthcare Drug Revenue by Type (2021-2026) & (US$ Million) Table 142. China Consumer Healthcare Drug Revenue by Type (2027-2032) & (US$ Million) Table 143. China Consumer Healthcare Drug Revenue by Application (2021-2026) & (US$ Million) Table 144. China Consumer Healthcare Drug Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Consumer Healthcare Drug Revenue by Type (2021-2026) & (US$ Million) Table 146. Asia Consumer Healthcare Drug Revenue by Type (2027-2032) & (US$ Million) Table 147. Asia Consumer Healthcare Drug Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Consumer Healthcare Drug Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Consumer Healthcare Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Consumer Healthcare Drug Revenue by Region (US$ Million) & (2021-2026) Table 151. Asia Consumer Healthcare Drug Revenue by Region (US$ Million) & (2027-2032) Table 152. SAMEA Consumer Healthcare Drug Revenue by Type (2021-2026) & (US$ Million) Table 153. SAMEA Consumer Healthcare Drug Revenue by Type (2027-2032) & (US$ Million) Table 154. SAMEA Consumer Healthcare Drug Revenue by Application (2021-2026) & (US$ Million) Table 155. SAMEA Consumer Healthcare Drug Revenue by Application (2027-2032) & (US$ Million) Table 156. SAMEA Consumer Healthcare Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. SAMEA Consumer Healthcare Drug Revenue by Country (2021-2026) & (US$ Million) Table 158. SAMEA Consumer Healthcare Drug Revenue by Country (US$ Million) & (2027-2032) Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Consumer Healthcare Drug Image Figure 2. Global Consumer Healthcare Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Consumer Healthcare Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Patch Image Figure 5. Oral Liquid Image Figure 6. Solid Preparations Image Figure 7. Other Image Figure 8. Global Consumer Healthcare Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Consumer Healthcare Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Retail Pharmacy Image Figure 12. Other Image Figure 13. Global Consumer Healthcare Drug Market Size (US$ Million) & (2021-2032) Figure 14. Global Consumer Healthcare Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Consumer Healthcare Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Consumer Healthcare Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Consumer Healthcare Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Consumer Healthcare Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Consumer Healthcare Drug Revenue Market Share by Type (2021-2032) Figure 21. Global Consumer Healthcare Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Consumer Healthcare Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Consumer Healthcare Drug Revenue Market Share by Application (2021-2032) Figure 24. North America Consumer Healthcare Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Consumer Healthcare Drug Revenue Share by Type (2021-2032) Figure 26. North America Consumer Healthcare Drug Revenue Share by Application (2021-2032) Figure 27. North America Consumer Healthcare Drug Revenue Share by Country (2021-2032) Figure 28. United States Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Consumer Healthcare Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Consumer Healthcare Drug Revenue Share by Type (2021-2032) Figure 33. Europe Consumer Healthcare Drug Revenue Share by Application (2021-2032) Figure 34. Europe Consumer Healthcare Drug Revenue Share by Country (2021-2032) Figure 35. Germany Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Consumer Healthcare Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Consumer Healthcare Drug Revenue Share by Type (2021-2032) Figure 45. China Consumer Healthcare Drug Revenue Share by Application (2021-2032) Figure 46. Asia Consumer Healthcare Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Consumer Healthcare Drug Revenue Share by Type (2021-2032) Figure 48. Asia Consumer Healthcare Drug Revenue Share by Application (2021-2032) Figure 49. Asia Consumer Healthcare Drug Revenue Share by Region (2021-2032) Figure 50. Japan Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Consumer Healthcare Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Consumer Healthcare Drug Revenue Share by Type (2021-2032) Figure 58. SAMEA Consumer Healthcare Drug Revenue Share by Application (2021-2032) Figure 59. SAMEA Consumer Healthcare Drug Revenue Share by Country (2021-2032) Figure 60. Brazil Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Consumer Healthcare Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Patch
  • Oral Liquid
  • Solid Preparations
  • Other
Applications
  • Hospital
  • Retail Pharmacy
  • Other
Companies covered
  • Takeda
  • Teva
  • Shanghai Pharmaceuticals
  • Sanofi
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Hualan Bio
  • North China Pharmaceutical
  • Hengrui Medicine
  • GlaxoSmithKline
  • Bayer
  • AbbVie
  • Sinopharm Group
  • Livzon Group
  • Fosun Pharma
  • East China Medicine
  • CR Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Consumer Healthcare Drug Market by Type
  3. 1.2.1 Global Consumer Healthcare Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Patch
  5. 1.2.3 Oral Liquid
  6. 1.2.4 Solid Preparations
  7. 1.2.5 Other
  8. 1.3 Consumer Healthcare Drug Market by Application
  9. 1.3.1 Global Consumer Healthcare Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Retail Pharmacy
  12. 1.3.4 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Consumer Healthcare Drug Market Dynamics
  1. 2.1 Consumer Healthcare Drug Industry Trends
  2. 2.2 Consumer Healthcare Drug Industry Drivers
  3. 2.3 Consumer Healthcare Drug Industry Opportunities and Challenges
  4. 2.4 Consumer Healthcare Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Consumer Healthcare Drug Market Perspective (2021-2032)
  2. 3.2 Global Consumer Healthcare Drug Growth Trends by Region
  3. 3.2.1 Global Consumer Healthcare Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Consumer Healthcare Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Consumer Healthcare Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Consumer Healthcare Drug Revenue by Players
  2. 4.1.1 Global Consumer Healthcare Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Consumer Healthcare Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Consumer Healthcare Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Consumer Healthcare Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Consumer Healthcare Drug Key Players Headquarters & Area Served
  7. 4.4 Global Consumer Healthcare Drug Players, Product Type & Application
  8. 4.5 Global Consumer Healthcare Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Consumer Healthcare Drug Market CR5 and HHI
  11. 4.6.3 2025 Consumer Healthcare Drug Tier 1, Tier 2, and Tier 3
5 Consumer Healthcare Drug Market Size by Type
  1. 5.1 Global Consumer Healthcare Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Consumer Healthcare Drug Revenue by Type (2021-2032)
  3. 5.3 Global Consumer Healthcare Drug Revenue Market Share by Type (2021-2032)
6 Consumer Healthcare Drug Market Size by Application
  1. 6.1 Global Consumer Healthcare Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Consumer Healthcare Drug Revenue by Application (2021-2032)
  3. 6.3 Global Consumer Healthcare Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Consumer Healthcare Drug Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Teva Consumer Healthcare Drug Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Shanghai Pharmaceuticals
  14. 7.3.1 Shanghai Pharmaceuticals Company Information
  15. 7.3.2 Shanghai Pharmaceuticals Business Overview
  16. 7.3.3 Shanghai Pharmaceuticals Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Shanghai Pharmaceuticals Consumer Healthcare Drug Product Portfolio
  18. 7.3.5 Shanghai Pharmaceuticals Recent Developments
  19. 7.4 Sanofi
  20. 7.4.1 Sanofi Company Information
  21. 7.4.2 Sanofi Business Overview
  22. 7.4.3 Sanofi Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi Consumer Healthcare Drug Product Portfolio
  24. 7.4.5 Sanofi Recent Developments
  25. 7.5 Johnson & Johnson
  26. 7.5.1 Johnson & Johnson Company Information
  27. 7.5.2 Johnson & Johnson Business Overview
  28. 7.5.3 Johnson & Johnson Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Johnson & Johnson Consumer Healthcare Drug Product Portfolio
  30. 7.5.5 Johnson & Johnson Recent Developments
  31. 7.6 Merck & Co.
  32. 7.6.1 Merck & Co. Company Information
  33. 7.6.2 Merck & Co. Business Overview
  34. 7.6.3 Merck & Co. Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Merck & Co. Consumer Healthcare Drug Product Portfolio
  36. 7.6.5 Merck & Co. Recent Developments
  37. 7.7 Pfizer
  38. 7.7.1 Pfizer Company Information
  39. 7.7.2 Pfizer Business Overview
  40. 7.7.3 Pfizer Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Pfizer Consumer Healthcare Drug Product Portfolio
  42. 7.7.5 Pfizer Recent Developments
  43. 7.8 Hualan Bio
  44. 7.8.1 Hualan Bio Company Information
  45. 7.8.2 Hualan Bio Business Overview
  46. 7.8.3 Hualan Bio Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Hualan Bio Consumer Healthcare Drug Product Portfolio
  48. 7.8.5 Hualan Bio Recent Developments
  49. 7.9 North China Pharmaceutical
  50. 7.9.1 North China Pharmaceutical Company Information
  51. 7.9.2 North China Pharmaceutical Business Overview
  52. 7.9.3 North China Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 North China Pharmaceutical Consumer Healthcare Drug Product Portfolio
  54. 7.9.5 North China Pharmaceutical Recent Developments
  55. 7.10 Hengrui Medicine
  56. 7.10.1 Hengrui Medicine Company Information
  57. 7.10.2 Hengrui Medicine Business Overview
  58. 7.10.3 Hengrui Medicine Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Hengrui Medicine Consumer Healthcare Drug Product Portfolio
  60. 7.10.5 Hengrui Medicine Recent Developments
  61. 7.11 GlaxoSmithKline
  62. 7.11.1 GlaxoSmithKline Company Information
  63. 7.11.2 GlaxoSmithKline Business Overview
  64. 7.11.3 GlaxoSmithKline Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GlaxoSmithKline Consumer Healthcare Drug Product Portfolio
  66. 7.11.5 GlaxoSmithKline Recent Developments
  67. 7.12 Bayer
  68. 7.12.1 Bayer Company Information
  69. 7.12.2 Bayer Business Overview
  70. 7.12.3 Bayer Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Bayer Consumer Healthcare Drug Product Portfolio
  72. 7.12.5 Bayer Recent Developments
  73. 7.13 AbbVie
  74. 7.13.1 AbbVie Company Information
  75. 7.13.2 AbbVie Business Overview
  76. 7.13.3 AbbVie Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 AbbVie Consumer Healthcare Drug Product Portfolio
  78. 7.13.5 AbbVie Recent Developments
  79. 7.14 Sinopharm Group
  80. 7.14.1 Sinopharm Group Company Information
  81. 7.14.2 Sinopharm Group Business Overview
  82. 7.14.3 Sinopharm Group Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Sinopharm Group Consumer Healthcare Drug Product Portfolio
  84. 7.14.5 Sinopharm Group Recent Developments
  85. 7.15 Livzon Group
  86. 7.15.1 Livzon Group Company Information
  87. 7.15.2 Livzon Group Business Overview
  88. 7.15.3 Livzon Group Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Livzon Group Consumer Healthcare Drug Product Portfolio
  90. 7.15.5 Livzon Group Recent Developments
  91. 7.16 Fosun Pharma
  92. 7.16.1 Fosun Pharma Company Information
  93. 7.16.2 Fosun Pharma Business Overview
  94. 7.16.3 Fosun Pharma Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Fosun Pharma Consumer Healthcare Drug Product Portfolio
  96. 7.16.5 Fosun Pharma Recent Developments
  97. 7.17 East China Medicine
  98. 7.17.1 East China Medicine Company Information
  99. 7.17.2 East China Medicine Business Overview
  100. 7.17.3 East China Medicine Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  101. 7.17.4 East China Medicine Consumer Healthcare Drug Product Portfolio
  102. 7.17.5 East China Medicine Recent Developments
  103. 7.18 CR Pharmaceutical
  104. 7.18.1 CR Pharmaceutical Company Information
  105. 7.18.2 CR Pharmaceutical Business Overview
  106. 7.18.3 CR Pharmaceutical Consumer Healthcare Drug Revenue and Gross Margin (2021-2026)
  107. 7.18.4 CR Pharmaceutical Consumer Healthcare Drug Product Portfolio
  108. 7.18.5 CR Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Consumer Healthcare Drug Revenue (2021-2032)
  2. 8.2 North America Consumer Healthcare Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Consumer Healthcare Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Consumer Healthcare Drug Revenue by Type (2027-2032)
  5. 8.3 North America Consumer Healthcare Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Consumer Healthcare Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Consumer Healthcare Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Consumer Healthcare Drug Revenue by Application (2027-2032)
  9. 8.5 North America Consumer Healthcare Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Consumer Healthcare Drug Revenue by Country
  11. 8.6.1 North America Consumer Healthcare Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Consumer Healthcare Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Consumer Healthcare Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Consumer Healthcare Drug Revenue (2021-2032)
  2. 9.2 Europe Consumer Healthcare Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Consumer Healthcare Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Consumer Healthcare Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Consumer Healthcare Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Consumer Healthcare Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Consumer Healthcare Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Consumer Healthcare Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Consumer Healthcare Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Consumer Healthcare Drug Revenue by Country
  11. 9.6.1 Europe Consumer Healthcare Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Consumer Healthcare Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Consumer Healthcare Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Consumer Healthcare Drug Revenue (2021-2032)
  2. 10.2 China Consumer Healthcare Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Consumer Healthcare Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Consumer Healthcare Drug Revenue by Type (2027-2032)
  5. 10.3 China Consumer Healthcare Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Consumer Healthcare Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Consumer Healthcare Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Consumer Healthcare Drug Revenue by Application (2027-2032)
  9. 10.5 China Consumer Healthcare Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Consumer Healthcare Drug Revenue (2021-2032)
  2. 11.2 Asia Consumer Healthcare Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Consumer Healthcare Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Consumer Healthcare Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Consumer Healthcare Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Consumer Healthcare Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Consumer Healthcare Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Consumer Healthcare Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Consumer Healthcare Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Consumer Healthcare Drug Revenue by Country
  11. 11.6.1 Asia Consumer Healthcare Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Consumer Healthcare Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Consumer Healthcare Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Consumer Healthcare Drug Revenue (2021-2032)
  2. 12.2 SAMEA Consumer Healthcare Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Consumer Healthcare Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Consumer Healthcare Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Consumer Healthcare Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Consumer Healthcare Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Consumer Healthcare Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Consumer Healthcare Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Consumer Healthcare Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Consumer Healthcare Drug Revenue by Country
  11. 12.6.1 SAMEA Consumer Healthcare Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Consumer Healthcare Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Consumer Healthcare Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst